Hydantoin derivatives for treating complications of diabetes

Details Hydantoin derivatives for treating complications of diabetes Hydantoin derivatives for treating complications of diabetes

1987-08-28

1989-08-29

Schwartz, Richard A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514253, 514278, 514382, 5142335, 544 70, 544230, 546 15, 548253, 548309, A61K 31415, C07D491107

Patent

active

048617920

ABSTRACT:
Hydantoin derivatives and salts thereof, intermediates therefor, process for the preparation thereof, and medicines containing the derivative, wherein said derivatives have the formula ##STR1## wherein one of V and W is hydrogen and the other is a halogenomethyl group, 1H-tetrazol-5-yl radical, --COOR group,

REFERENCES:
patent: 4740517 (1988-04-01), Kurono et al.
Kinoshita, J. H. et al., Jap.J.Ophthalmol., vol. 20, 339-410, 1976.
Kenneth H. Gabbay, Int. Congr. Ser. Excerpta Med., vol. 403, p. 594, 1977.
Peterson, M. J. et al., Metabolism, vol. 28, p. 456, 1979.
Ziegler, E., et al., Liebigs Ann. Chem., pp. 1552-1556, 1973.
Witiak, D. T. et al., J. Med. Chem., vol. 14, No. 8, 758-756 (1971).

Affiliated with

Also associated with

Rating

Hydantoin derivatives for treating complications of diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydantoin derivatives for treating complications of diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin derivatives for treating complications of diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2238605